Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: In many malaria-endemic countries, increasing resistance may soon compromise the efficacy of sulphadoxine-pyrimethamine (SP) for intermittent preventative treatment (IPT) of malaria in pregnancy. Artemisinin-based IPT regimens represent a promising potential alternative to SP. Pharmacokinetic and safety data supporting the use of artemisinin derivatives in pregnancy are urgently needed. Methods: Subjects included pregnant women with asymptomatic falciparum parasitaemia between 22-26 weeks (n = 13) or 32-36 weeks gestation (n = 13), the same women at three months postpartum, and 25 non-pregnant parasitaemic controls. All subjects received 200 mg orally administered AS. Plasma total and free levels of AS and its active metabolite DHA were determined using a validated LC-MS method. Non-compartmental pharmacokinetic analysis was performed using standard methods. Results: All pregnant women delivered live babies. The median birth weight was 3025 grams [range 2130, 3620]; 2 of 26 babies had birth weights less than 2500 grams. Rates of parasite clearance by 12 hours post-dose were high and comparable among the groups. Rapid elimination of AS was observed in all three groups. The 90% CI for the pregnancy:postpartum ratio of geometric means for total and free AUC fell within the pre-specified 0.66 - 1.50 therapeutic equivalence interval. However, more pronounced pharmacokinetic differences were observed between the pregnancy and control subjects, with the 90% CI for the pregnancy:control ratio of geometric means for both total 0.68 (90% CI 0.57-0.81) and free AUC 0.78 (90% CI 0.63-0.95) not fully contained within the 0.66 - 1.50 interval. All subjects cleared parasites rapidly, and there was no difference in the percentage of women who were parasitaemic 12 hours after dosing. Conclusions: A single dose of orally administered AS was found to be both effective and without adverse effects in this study of second and third trimester pregnant women in the DRC. Although DHA AUC during pregnancy and postpartum were similar, the AUC for the pregnant group was less than the non-pregnant controls. The findings of this study suggest that additional studies on the pharmacokinetics of AS in pregnant women are needed. Trial Registration: ClinicalTrials.gov: NCT00538382
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sex Differences in Pharmacokinetics and Pharmacodynamics
Soldin, O. P., & Mattison, D. R. (2009) · Clinical Pharmacokinetics · doi:10.2165/00003088-200948030-00001 · Cited by 1,163 · cited 1×
“Pregnancy may increase metabolism of drugs, possibly through increased hepatic blood flow and increased free-fraction of drugs [25,26].”
BackgroundThe burden of malaria in pregnancy in malaria-endemic areas
Steketee, R., Nahlen, B., Parise, M., & Menendez, C. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.28 · Cited by 1,063
The Impact of Placental Malaria on Gestational Age and Birth Weight
Menendez, C., Ordi, J., Ismail, M. R., Ventura, P. J., Aponte, J. J., Kahigwa, E., Font, F., & Alonso, P. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315449 · Cited by 467 · cited 1×
“Pregnant women are particularly susceptible to malaria, which can lead to intrauterine growth restriction, low birth weight, prematurity, and other poor birth outcomes [1-7].”
BackgroundReducing the burden of malaria in pregnancy by preventive strategies
Menéndez, C., D'Alessandro, U., & ter Kuile, F. O. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70024-5 · Cited by 188 · cited 1×
“Pregnant women are particularly susceptible to malaria, which can lead to intrauterine growth restriction, low birth weight, prematurity, and other poor birth outcomes [1-7].”
BackgroundEstimating fetal age: effect of head shape on BPD
Hadlock, F., Deter, R., Carpenter, R., & Park, S. (1981) · American Journal of Roentgenology · doi:10.2214/ajr.137.1.83 · Cited by 160
Pharmacokinetics of caffeine during and after pregnancy
Brazier, J. L., Ritter, J., Berland, M., Khenfer, D., & Faucon, G. (2017) · Developmental Pharmacology and Therapeutics · doi:10.1159/000457332 · Cited by 155 · cited 1×
“In a study of caffeine during and after pregnancy, the pharmacokinetics returned to predicted values in non-pregnant women within 4 days postpartum [27].”
BackgroundMcGready, R., Stepniewska, K., Lindegardh, N., Ashley, E. A., La, Y., Singhasivanon, P., White, N. J., & Nosten, F. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0199-7 · Cited by 115
McGready, R., Stepniewska, K., Ward, S. A., Cho, T., Gilveray, G., Looareesuwan, S., White, N. J., & Nosten, F. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0118-y · Cited by 101 · cited 2×
“A prior study conducted by McGready et al in Thailand suggested that pregnancy was associated with decreased exposure to DHA, and increased DHA CL/F and Vd/F, as compared to results obtained in previous studies with non-pregnant adults [16].”
BackgroundResult
Cited by
Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review
Pariente, G., Leibson, T., Carls, A., Adams-Webber, T., Ito, S., & Koren, G. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002160 · Cited by 336
Morris, C. A., Duparc, S., Borghini-Fuhrer, I., Jung, D., Shin, C.-S., & Fleckenstein, L. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-263 · Cited by 232
“Onyamboko et al [53] examined the PK of DHA following the oral administration of 200 mg AS to 26 2 and 3 trimester pregnant women with asymptomatic falciparum parasitaemia, the same women 3 months post-partum, and 25 matched asymptomatic parasitaemic female controls in the Democratic Republic of Congo.”
BackgroundMethodInfluentialSelf-citationRijken, M. J., McGready, R., Phyo, A. P., Lindegardh, N., Tarning, J., Laochan, N., Than, H. H., Mu, O., Win, A. K., Singhasivanon, P., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05067-11 · Cited by 75
“Plasma concentrations of the artemisinin derivatives artesunate or artemether and their common active metabolite DHA are reported to be low in pregnancy (14, 15, 17, 23), but this has not been studied for DHA-PPQ.”
BackgroundManyando, C., Kayentao, K., D’Alessandro, U., Okafor, H. U., Juma, E., & Hamed, K. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-141 · Cited by 62
“These analyses, together with recent results suggesting that DHA clearance may be approximately 42% higher in pregnant women [46,47], support the view that further study of the pharmacokinetics of AL in pregnancy would be of benefit to help maintain confidence in dosing regimens and ensure that pregnant women receive…”
ResultThe Global Network for Women's and Children's Health Research: A model of capacity-building research
Koso-Thomas, M., & McClure, E. M. (2015) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2015.04.004 · Cited by 48
“Training in health interventions has included neonatal resuscitation, birth attendant training in active management of third stage of labor, accurate data collection and reporting by the pregnancy and birth registry administrators, assessment of gestational age in pregnancy using tools and materials developed and vali…”
Method
Metadata
- Authors
- Onyamboko, M. A., Meshnick, S. R., Fleckenstein, L., Koch, M. A., Atibu, J., Lokomba, V., Douoguih, M., Hemingway-Foday, J., Wesche, D., Ryder, R. W., Bose, C., Wright, L. L., Tshefu, A. K., & Capparelli, E. V.
- Venue
- Malaria Journal
- Published
- 2011-02-28
- Volume
- 10
- Issue
- 1
- Pages
- 49-49
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W2159666937
- Cited by
- 37
- References
- 8
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.